Steve Cohen: portfolio of Point72 Asset Management
Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.
Source: 13F filing with the US Securities and Exchange Commission dated Aug 15, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2022. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 20.9B USD
- Positions
- 982
- Share of the ten largest
- 10.1%
The ten largest positions Q2 2022
- T-Mobile US 1.8%▲ +116.8%
- Visa Inc. 1.3%▲ +49.6%
- Argenx SE 1.0%▼ −27.4%
- Take-Two Interactive 0.9%▲ +734.4%
- Fidelity National Information Services 0.9%▲ +35.2%
- ServiceNow 0.9%▲ +313.3%
- Arista Networks 0.8%▲ +14.0%
- Humana 0.8%▲ +45.1%
- Meta Platforms 0.8%▲ +145.6%
- ConocoPhillips 0.8%▼ −8.0%
Show all positions of this quarter
Choose a quarter (50 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
All positions Q2 2022
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| Argenx SE | 1.0% | 574,967 | 217.8M USD | −27.4% reduced | Q1 2021 6 quarters |
| COP ConocoPhillips | 0.8% | 1,823,600 | 163.8M USD | −8.0% reduced | Q3 2020 8 quarters |
| SPGI S&P Global | 0.8% | 485,599 | 163.7M USD | −1.1% reduced | Q2 2021 5 quarters |
| CI Cigna | 0.7% | 591,239 | 155.8M USD | −26.4% reduced | Q4 2021 3 quarters |
| Seagen Inc | 0.7% | 857,822 | 151.8M USD | −38.4% reduced | Q1 2021 6 quarters |
| AMZN Amazon | 0.7% | 1,312,791 | 139.4M USD | −25.0% reducedafter 20:1 stock split | Q1 2017 22 quarters |
| MRK Merck & Co. | 0.5% | 1,196,400 | 109.1M USD | −66.6% reduced | Q2 2020 9 quarters |
| BKNG Booking Holdings | 0.5% | 61,080 | 106.8M USD | −59.6% reduced | Q1 2018 18 quarters |
| Krystal Biotech Inc | 0.5% | 1,574,275 | 103.4M USD | −8.5% reduced | Q2 2020 9 quarters |
| JBL Jabil | 0.5% | 1,980,800 | 101.4M USD | −34.4% reduced | Q2 2019 13 quarters |
| Select Sector SPDR TR | 0.5% | 1,390,000 | 99.4M USD | −1.1% reduced | Q1 2019 14 quarters |
| MNST Monster Beverage | 0.5% | 1,024,511 | 95.0M USD | −32.1% reduced | Q3 2021 4 quarters |
| ADI Analog Devices | 0.4% | 571,516 | 83.5M USD | −60.0% reduced | Q2 2020 9 quarters |
| BP BP (ADR) | 0.4% | 2,898,600 | 82.2M USD | −23.7% reduced | Q2 2021 5 quarters |
| LUV Southwest Airlines | 0.4% | 2,251,205 | 81.3M USD | −23.1% reduced | Q4 2021 3 quarters |
| FDX FedEx | 0.4% | 349,437 | 79.2M USD | −66.4% reduced | Q1 2021 6 quarters |
| Antero Resources Corp | 0.3% | 2,125,177 | 65.1M USD | −22.8% reduced | Q3 2020 8 quarters |
| KHC Kraft Heinz | 0.3% | 1,613,392 | 61.5M USD | −3.6% reduced | Q4 2021 3 quarters |
| TSM Taiwan Semiconductor Manufacturing (ADR) | 0.3% | 735,471 | 60.1M USD | −11.8% reduced | Q3 2021 4 quarters |
| Shell PLC | 0.3% | 1,097,200 | 57.4M USD | −38.0% reduced | Q1 2022 2 quarters |
| VMC Vulcan Materials Company | 0.3% | 394,179 | 56.0M USD | −12.8% reduced | Q1 2021 6 quarters |
| Fibrogen Inc | 0.3% | 5,066,292 | 53.5M USD | −13.1% reduced | Q3 2021 4 quarters |
| MA Mastercard | 0.2% | 163,726 | 51.7M USD | −45.7% reduced | Q4 2020 7 quarters |
| CEG Constellation Energy | 0.2% | 857,581 | 49.1M USD | −37.8% reduced | Q1 2022 2 quarters |
| Capri Holdings Limited | 0.2% | 1,177,370 | 48.3M USD | −34.4% reduced | Q3 2020 8 quarters |
| JNJ Johnson & Johnson | 0.2% | 267,385 | 47.5M USD | −55.5% reduced | Q3 2021 4 quarters |
| CSX CSX Corporation | 0.2% | 1,595,201 | 46.4M USD | −19.4% reduced | Q3 2020 8 quarters |
| Jazz Pharmaceuticals PLC | 0.2% | 293,269 | 45.8M USD | −38.4% reduced | Q3 2021 4 quarters |
| Post HLDGS Inc | 0.2% | 536,921 | 44.2M USD | −54.7% reduced | Q4 2020 7 quarters |
| GDDY GoDaddy | 0.2% | 614,900 | 42.8M USD | −19.7% reduced | Q3 2021 4 quarters |
| Lantheus HLDGS Inc | 0.2% | 641,311 | 42.3M USD | −29.7% reduced | Q1 2022 2 quarters |
| HLT Hilton Worldwide | 0.2% | 379,373 | 42.3M USD | −48.9% reduced | Q4 2021 3 quarters |
| ROST Ross Stores | 0.2% | 562,712 | 39.5M USD | −44.5% reduced | Q4 2021 3 quarters |
| Rh | 0.2% | 178,338 | 37.9M USD | −35.8% reduced | Q3 2021 4 quarters |
| DLR Digital Realty | 0.2% | 290,223 | 37.7M USD | −47.3% reduced | Q3 2021 4 quarters |
| WAT Waters Corporation | 0.2% | 113,466 | 37.6M USD | −9.4% reduced | Q1 2022 2 quarters |
| Tenable HLDGS Inc | 0.2% | 800,000 | 36.3M USD | −21.0% reduced | Q2 2021 5 quarters |
| ISRG Intuitive Surgical | 0.2% | 179,700 | 36.1M USD | −22.7% reduced | Q1 2021 6 quarters |
| Stellantis N.v | 0.2% | 2,855,447 | 35.3M USD | −22.8% reduced | Q1 2022 2 quarters |
| Texas Roadhouse Inc | 0.2% | 456,956 | 33.4M USD | −43.3% reduced | Q1 2020 10 quarters |
| Hyatt Hotels Corp | 0.2% | 444,410 | 32.8M USD | −25.7% reduced | Q3 2021 4 quarters |
| Insmed Inc | 0.2% | 1,660,854 | 32.8M USD | −29.8% reduced | Q3 2018 16 quarters |
| AVY Avery Dennison | 0.2% | 197,600 | 32.0M USD | −44.1% reduced | Q4 2021 3 quarters |
| Sarepta Therapeutics Inc | 0.2% | 425,507 | 31.9M USD | −70.6% reduced | Q1 2021 6 quarters |
| MSI Motorola Solutions | 0.2% | 151,835 | 31.8M USD | −69.3% reduced | Q1 2021 6 quarters |
| FTV Fortive | 0.2% | 582,400 | 31.7M USD | −18.3% reduced | Q1 2022 2 quarters |
| Bellring Brands Inc | 0.1% | 1,227,670 | 30.6M USD | −53.9% reduced | Q1 2022 2 quarters |
| Atara Biotherapeutics Inc | 0.1% | 3,877,200 | 30.2M USD | −5.5% reduced | Q4 2020 7 quarters |
| Xenon Pharmaceuticals Inc | 0.1% | 901,506 | 27.4M USD | −58.0% reduced | Q1 2015 30 quarters |
| Ping Identity Hldg Corp | 0.1% | 1,492,300 | 27.1M USD | −12.4% reduced | Q2 2021 5 quarters |
| Hf Sinclair Corp | 0.1% | 560,801 | 25.3M USD | −31.6% reduced | Q1 2022 2 quarters |
| Sotera Health Co | 0.1% | 1,241,300 | 24.3M USD | −58.5% reduced | Q4 2021 3 quarters |
| Bicycle Therapeutics PLC | 0.1% | 1,445,000 | 24.2M USD | −10.8% reduced | Q4 2019 11 quarters |
| Aclaris Therapeutics Inc | 0.1% | 1,733,900 | 24.2M USD | −23.9% reduced | Q1 2021 6 quarters |
| Relmada Therapeutics Inc | 0.1% | 1,272,574 | 24.2M USD | −3.0% reduced | Q2 2020 9 quarters |
| WFC Wells Fargo | 0.1% | 588,898 | 23.1M USD | −25.9% reduced | Q1 2021 6 quarters |
| KKR KKR & Co. | 0.1% | 497,000 | 23.0M USD | −35.4% reduced | Q3 2021 4 quarters |
| Qorvo Inc | 0.1% | 233,635 | 22.0M USD | −60.4% reduced | Q2 2021 5 quarters |
| Essential Utils Inc | 0.1% | 471,857 | 21.6M USD | −1.9% reduced | Q3 2021 4 quarters |
| Evolent Health Inc | < 0.1% | 678,702 | 20.8M USD | −52.1% reduced | Q3 2021 4 quarters |
| Ideaya Biosciences Inc | < 0.1% | 1,509,000 | 20.8M USD | −18.3% reduced | Q2 2019 13 quarters |
| Wendys Co | < 0.1% | 1,084,514 | 20.5M USD | −56.6% reduced | Q3 2021 4 quarters |
| Azenta Inc | < 0.1% | 282,380 | 20.4M USD | −46.5% reduced | Q2 2021 5 quarters |
| Palomar HLDGS Inc | < 0.1% | 307,477 | 19.8M USD | −30.1% reduced | Q4 2021 3 quarters |
| Privia Health Group Inc | < 0.1% | 660,300 | 19.2M USD | −56.3% reduced | Q4 2021 3 quarters |
| Berry Global Group Inc | < 0.1% | 350,200 | 19.1M USD | −35.2% reduced | Q2 2021 5 quarters |
| Stifel Finl Corp | < 0.1% | 334,236 | 18.7M USD | −41.2% reduced | Q3 2021 4 quarters |
| Forgerock Inc | < 0.1% | 860,034 | 18.4M USD | −24.5% reduced | Q1 2022 2 quarters |
| Phreesia Inc | < 0.1% | 731,700 | 18.3M USD | −45.9% reduced | Q1 2022 2 quarters |
| Angiodynamics Inc | < 0.1% | 927,203 | 17.9M USD | −19.0% reduced | Q4 2020 7 quarters |
| Affimed N V | < 0.1% | 6,449,020 | 17.9M USD | −31.1% reduced | Q3 2019 12 quarters |
| AES AES Corporation | < 0.1% | 850,000 | 17.9M USD | −57.5% reduced | Q3 2021 4 quarters |
| CBRE CBRE Group | < 0.1% | 240,900 | 17.7M USD | −0.5% reduced | Q1 2022 2 quarters |
| Carlyle Group Inc | < 0.1% | 559,700 | 17.7M USD | −6.7% reduced | Q3 2021 4 quarters |
| Rexford Indl Rlty Inc | < 0.1% | 304,277 | 17.5M USD | −2.9% reduced | Q1 2022 2 quarters |
| Arvinas Inc | < 0.1% | 411,548 | 17.3M USD | −52.0% reduced | Q1 2019 14 quarters |
| Anaptysbio Inc | < 0.1% | 851,800 | 17.3M USD | −35.4% reduced | Q4 2021 3 quarters |
| TRGP Targa Resources | < 0.1% | 287,342 | 17.1M USD | −74.1% reduced | Q3 2019 12 quarters |
| Ngm Biopharmaceuticals Inc | < 0.1% | 1,320,662 | 16.9M USD | −58.9% reduced | Q1 2020 10 quarters |
| ETR Entergy | < 0.1% | 150,200 | 16.9M USD | −86.7% reduced | Q1 2022 2 quarters |
| APD Air Products | < 0.1% | 69,570 | 16.7M USD | −19.0% reduced | Q1 2022 2 quarters |
| Pembina Pipeline Corp | < 0.1% | 469,800 | 16.6M USD | −0.1% reduced | Q1 2022 2 quarters |
| Ultragenyx Pharmaceutical In | < 0.1% | 273,515 | 16.3M USD | −14.1% reduced | Q4 2020 7 quarters |
| Pioneer Nat Res Co | < 0.1% | 71,137 | 15.9M USD | −85.1% reduced | Q3 2021 4 quarters |
| Sanofi | < 0.1% | 315,984 | 15.8M USD | −76.2% reduced | Q1 2018 18 quarters |
| Armstrong World Inds Inc New | < 0.1% | 210,539 | 15.8M USD | −28.2% reduced | Q1 2022 2 quarters |
| MRSH Marsh McLennan | < 0.1% | 101,400 | 15.7M USD | −30.8% reduced | Q2 2021 5 quarters |
| DDOG Datadog | < 0.1% | 157,200 | 15.0M USD | −60.5% reduced | Q2 2021 5 quarters |
| BF-B Brown–Forman | < 0.1% | 206,751 | 14.5M USD | −33.5% reduced | Q4 2021 3 quarters |
| Fabrinet | < 0.1% | 175,000 | 14.2M USD | −58.3% reduced | Q1 2021 6 quarters |
| Sunstone Hotel Invs Inc New | < 0.1% | 1,430,551 | 14.2M USD | −14.2% reduced | Q4 2021 3 quarters |
| DUK Duke Energy | < 0.1% | 131,300 | 14.1M USD | −84.3% reduced | Q4 2021 3 quarters |
| Arrowhead Pharmaceuticals In | < 0.1% | 395,868 | 13.9M USD | −29.4% reduced | Q2 2021 5 quarters |
| OPEN Opendoor Technologies | < 0.1% | 2,891,266 | 13.6M USD | −60.1% reduced | Q3 2021 4 quarters |
| Abiomed Inc | < 0.1% | 53,999 | 13.4M USD | −39.9% reduced | Q1 2022 2 quarters |
| Kezar Life Sciences Inc | < 0.1% | 1,608,400 | 13.3M USD | −29.0% reduced | Q4 2021 3 quarters |
| Biomarin Pharmaceutical Inc | < 0.1% | 147,871 | 12.3M USD | −59.7% reduced | Q3 2020 8 quarters |
| Shockwave Med Inc | < 0.1% | 62,176 | 11.9M USD | −31.6% reduced | Q4 2021 3 quarters |
| Macom Tech Solutions HLDGS I | < 0.1% | 254,200 | 11.7M USD | −48.1% reduced | Q1 2022 2 quarters |
| Mereo Biopharma Group PLC | < 0.1% | 10,035,970 | 11.2M USD | −12.7% reduced | Q1 2021 6 quarters |
| Archaea Energy Inc | < 0.1% | 723,053 | 11.2M USD | −38.0% reduced | Q4 2021 3 quarters |
| Lithia Mtrs Inc | < 0.1% | 40,800 | 11.2M USD | −9.0% reduced | Q3 2021 4 quarters |
| HAS Hasbro | < 0.1% | 134,576 | 11.0M USD | −84.9% reduced | Q4 2021 3 quarters |
| Irhythm Technologies Inc | < 0.1% | 99,427 | 10.7M USD | −47.3% reduced | Q4 2021 3 quarters |
| Exelixis Inc | < 0.1% | 512,600 | 10.7M USD | −92.5% reduced | Q1 2020 10 quarters |
| DOC Healthpeak Properties | < 0.1% | 397,383 | 10.3M USD | −35.8% reduced | Q1 2022 2 quarters |
| Liveperson Inc | < 0.1% | 698,862 | 9.9M USD | −31.9% reduced | Q3 2021 4 quarters |
| ASML ASML Holding (ADR) | < 0.1% | 19,921 | 9.5M USD | −52.0% reduced | Q3 2020 8 quarters |
| Academy Sports & Outdoors In | < 0.1% | 266,142 | 9.5M USD | −75.0% reduced | Q2 2021 5 quarters |
| Dyne Therapeutics Inc | < 0.1% | 1,366,400 | 9.4M USD | −27.6% reduced | Q1 2021 6 quarters |
| Azek Co Inc | < 0.1% | 545,000 | 9.1M USD | −16.7% reduced | Q2 2021 5 quarters |
| Array Technologies Inc | < 0.1% | 823,790 | 9.1M USD | −35.6% reduced | Q4 2020 7 quarters |
| WRB W. R. Berkley Corporation | < 0.1% | 129,461 | 8.8M USD | −50.8% reduced | Q2 2020 9 quarters |
| WDC Western Digital | < 0.1% | 189,803 | 8.5M USD | −31.0% reduced | Q3 2020 8 quarters |
| MTB M&T Bank | < 0.1% | 53,218 | 8.5M USD | −53.2% reduced | Q4 2021 3 quarters |
| Revance Therapeutics Inc | < 0.1% | 605,574 | 8.4M USD | −23.0% reduced | Q3 2021 4 quarters |
| Callaway Golf Co | < 0.1% | 401,747 | 8.2M USD | −52.4% reduced | Q1 2022 2 quarters |
| Oyster Pt Pharma Inc | < 0.1% | 1,889,096 | 8.2M USD | −4.1% reduced | Q3 2021 4 quarters |
| FCX Freeport-McMoRan | < 0.1% | 273,052 | 8.0M USD | −39.1% reduced | Q3 2021 4 quarters |
| Spectrum Brands HLDGS Inc Ne | < 0.1% | 97,010 | 8.0M USD | −7.1% reduced | Q1 2022 2 quarters |
| Sabra Health Care REIT Inc | < 0.1% | 565,924 | 7.9M USD | −68.2% reduced | Q1 2022 2 quarters |
| EXPD Expeditors International | < 0.1% | 80,100 | 7.8M USD | −76.4% reduced | Q1 2022 2 quarters |
| Vermilion Energy Inc | < 0.1% | 406,701 | 7.7M USD | −37.6% reduced | Q1 2022 2 quarters |
| Somalogic Inc | < 0.1% | 1,710,647 | 7.7M USD | −24.9% reduced | Q3 2021 4 quarters |
| Apollo Med HLDGS Inc | < 0.1% | 199,551 | 7.7M USD | −27.8% reduced | Q1 2022 2 quarters |
| ENPH Enphase Energy | < 0.1% | 39,209 | 7.7M USD | −65.2% reduced | Q3 2021 4 quarters |
| VICI Vici Properties | < 0.1% | 255,780 | 7.6M USD | −59.6% reduced | Q1 2022 2 quarters |
| Bunge Limited | < 0.1% | 83,900 | 7.6M USD | −77.8% reduced | Q2 2014 or earlier 33 quarters |
| Stem Inc | < 0.1% | 1,061,100 | 7.6M USD | −45.1% reduced | Q4 2021 3 quarters |
| Marketaxess HLDGS Inc | < 0.1% | 29,400 | 7.5M USD | −24.7% reduced | Q1 2022 2 quarters |
| XEL Xcel Energy | < 0.1% | 106,100 | 7.5M USD | −55.0% reduced | Q3 2021 4 quarters |
| CELH Celsius Holdings | < 0.1% | 113,912 | 7.4M USD | −3.7% reduced | Q1 2022 2 quarters |
| Rpm Intl Inc | < 0.1% | 90,416 | 7.1M USD | −54.9% reduced | Q1 2022 2 quarters |
| Dave & Busters Entmt Inc | < 0.1% | 213,792 | 7.0M USD | −69.3% reduced | Q3 2021 4 quarters |
| Kinsale Cap Group Inc | < 0.1% | 30,394 | 7.0M USD | −33.0% reduced | Q3 2021 4 quarters |
| Under Armour Inc | < 0.1% | 828,566 | 6.9M USD | −63.8% reduced | Q4 2020 7 quarters |
| Mgic Invt Corp Wis | < 0.1% | 527,900 | 6.7M USD | −3.4% reduced | Q3 2021 4 quarters |
| CFG Citizens Financial Group | < 0.1% | 178,353 | 6.4M USD | −42.9% reduced | Q2 2021 5 quarters |
| Tricida Inc | < 0.1% | 657,400 | 6.4M USD | −64.2% reduced | Q1 2021 6 quarters |
| Remitly Global Inc | < 0.1% | 819,785 | 6.3M USD | −11.0% reduced | Q3 2021 4 quarters |
| Planet Fitness Inc | < 0.1% | 90,126 | 6.1M USD | −68.8% reduced | Q1 2022 2 quarters |
| Bloomin Brands Inc | < 0.1% | 366,985 | 6.1M USD | −29.5% reduced | Q2 2021 5 quarters |
| SHIFT4 Pmts Inc | < 0.1% | 174,352 | 5.8M USD | −56.4% reduced | Q3 2020 8 quarters |
| MRVL Marvell Technology | < 0.1% | 122,999 | 5.4M USD | −93.8% reduced | Q1 2021 6 quarters |
| Adient PLC | < 0.1% | 179,500 | 5.3M USD | −31.1% reduced | Q1 2021 6 quarters |
| MET MetLife | < 0.1% | 82,987 | 5.2M USD | −78.5% reduced | Q1 2021 6 quarters |
| Continental Res Inc | < 0.1% | 79,458 | 5.2M USD | −30.1% reduced | Q1 2022 2 quarters |
| Merit Med Sys Inc | < 0.1% | 93,909 | 5.1M USD | −41.4% reduced | Q2 2021 5 quarters |
| Hertz Global HLDGS Inc | < 0.1% | 321,027 | 5.1M USD | −55.2% reduced | Q4 2021 3 quarters |
| Independence Rlty TR Inc | < 0.1% | 244,016 | 5.1M USD | −55.5% reduced | Q4 2021 3 quarters |
| Cytomx Therapeutics Inc | < 0.1% | 2,750,000 | 5.0M USD | −37.1% reduced | Q4 2020 7 quarters |
| Epr Pptys | < 0.1% | 105,798 | 5.0M USD | −73.8% reduced | Q1 2022 2 quarters |
| Pjt Partners Inc | < 0.1% | 69,233 | 4.9M USD | −7.7% reduced | Q1 2022 2 quarters |
| Vale S A | < 0.1% | 322,500 | 4.7M USD | −9.8% reduced | Q1 2022 2 quarters |
| Kb Home | < 0.1% | 165,100 | 4.7M USD | −64.8% reduced | Q1 2022 2 quarters |
| United Therapeutics Corp Del | < 0.1% | 19,815 | 4.7M USD | −89.9% reduced | Q2 2021 5 quarters |
| Pacwest Bancorp Del | < 0.1% | 174,848 | 4.7M USD | −56.4% reduced | Q2 2021 5 quarters |
| Alphatec HLDGS Inc | < 0.1% | 711,300 | 4.7M USD | −13.6% reduced | Q4 2020 7 quarters |
| Transalta Corp | < 0.1% | 385,000 | 4.4M USD | −63.8% reduced | Q3 2020 8 quarters |
| Comstock Res Inc | < 0.1% | 355,528 | 4.3M USD | −60.8% reduced | Q1 2022 2 quarters |
| EXE Expand Energy | < 0.1% | 52,200 | 4.2M USD | −92.2% reduced | Q1 2022 2 quarters |
| Olin Corp | < 0.1% | 90,102 | 4.2M USD | −78.1% reduced | Q1 2021 6 quarters |
| Toast Inc | < 0.1% | 306,200 | 4.0M USD | −21.9% reduced | Q1 2022 2 quarters |
| Golar Lng Ltd | < 0.1% | 172,556 | 3.9M USD | −92.5% reduced | Q2 2021 5 quarters |
| Hci Group Inc | < 0.1% | 57,307 | 3.9M USD | −71.3% reduced | Q1 2021 6 quarters |
| Pliant Therapeutics Inc | < 0.1% | 484,524 | 3.9M USD | −37.1% reduced | Q4 2021 3 quarters |
| Helmerich & Payne Inc | < 0.1% | 88,200 | 3.8M USD | −62.2% reduced | Q3 2021 4 quarters |
| Netstreit Corp | < 0.1% | 192,307 | 3.6M USD | −35.6% reduced | Q1 2022 2 quarters |
| Green Plains Inc | < 0.1% | 132,100 | 3.6M USD | −68.9% reduced | Q1 2021 6 quarters |
| Signet Jewelers Limited | < 0.1% | 64,835 | 3.5M USD | −75.1% reduced | Q3 2020 8 quarters |
| HPE Hewlett Packard Enterprise | < 0.1% | 259,240 | 3.4M USD | −71.6% reduced | Q1 2022 2 quarters |
| Fluence Energy Inc | < 0.1% | 355,200 | 3.4M USD | −55.4% reduced | Q4 2021 3 quarters |
| Replimune Group Inc | < 0.1% | 187,800 | 3.3M USD | −78.0% reduced | Q4 2021 3 quarters |
| Proterra Inc | < 0.1% | 701,000 | 3.3M USD | −24.4% reduced | Q2 2021 5 quarters |
| 2SEVENTY Bio Inc | < 0.1% | 238,300 | 3.1M USD | −23.3% reduced | Q4 2021 3 quarters |
| CRL Charles River Laboratories | < 0.1% | 14,513 | 3.1M USD | −81.5% reduced | Q3 2020 8 quarters |
| Tactile Sys Technology Inc | < 0.1% | 425,000 | 3.1M USD | −46.0% reduced | Q1 2022 2 quarters |
| Site Ctrs Corp | < 0.1% | 226,624 | 3.1M USD | −8.4% reduced | Q1 2022 2 quarters |
| Stag Indl Inc | < 0.1% | 97,332 | 3.0M USD | −76.9% reduced | Q4 2021 3 quarters |
| Impinj Inc | < 0.1% | 49,913 | 2.9M USD | −39.3% reduced | Q4 2021 3 quarters |
| NVO Novo Nordisk (ADR) | < 0.1% | 26,270 | 2.9M USD | −95.5% reduced | Q1 2022 2 quarters |
| Frontdoor Inc | < 0.1% | 115,000 | 2.8M USD | −1.5% reduced | Q1 2022 2 quarters |
| Prothena Corp PLC | < 0.1% | 99,900 | 2.7M USD | −42.3% reduced | Q2 2021 5 quarters |
| Gulfport Energy Corp | < 0.1% | 33,325 | 2.7M USD | −49.5% reduced | Q3 2021 4 quarters |
| Cameco Corp | < 0.1% | 125,000 | 2.6M USD | −57.7% reduced | Q1 2021 6 quarters |
| Figs Inc | < 0.1% | 279,700 | 2.5M USD | −71.4% reduced | Q1 2022 2 quarters |
| Ventyx Biosciences Inc | < 0.1% | 206,400 | 2.5M USD | −8.8% reduced | Q1 2022 2 quarters |
| Vertex Energy Inc | < 0.1% | 228,096 | 2.4M USD | −32.9% reduced | Q1 2022 2 quarters |
| Gh Research PLC | < 0.1% | 231,300 | 2.3M USD | −15.1% reduced | Q4 2021 3 quarters |
| Sunpower Corp | < 0.1% | 144,000 | 2.3M USD | −47.0% reduced | Q1 2022 2 quarters |
| FSLR First Solar | < 0.1% | 33,157 | 2.3M USD | −91.3% reduced | Q1 2022 2 quarters |
| EMR Emerson Electric | < 0.1% | 26,453 | 2.1M USD | −88.9% reduced | Q1 2022 2 quarters |
| AMP Ameriprise Financial | < 0.1% | 8,700 | 2.1M USD | −45.3% reduced | Q3 2021 4 quarters |
| Landec Corp | < 0.1% | 203,700 | 2.0M USD | −22.1% reduced | Q4 2021 3 quarters |
| Ishares TR | < 0.1% | 40,000 | 2.0M USD | −46.7% reduced | Q1 2020 10 quarters |
| Merrimack Pharmaceuticals In | < 0.1% | 335,108 | 2.0M USD | −1.9% reduced | Q2 2021 5 quarters |
| Lpl Finl HLDGS Inc | < 0.1% | 10,800 | 2.0M USD | −83.9% reduced | Q4 2020 7 quarters |
| Avid Bioservices Inc | < 0.1% | 128,600 | 2.0M USD | −58.7% reduced | Q1 2022 2 quarters |
| Nanostring Technologies Inc | < 0.1% | 149,989 | 1.9M USD | −41.5% reduced | Q3 2020 8 quarters |
| Amdocs Ltd | < 0.1% | 22,300 | 1.9M USD | −89.9% reduced | Q1 2022 2 quarters |
| Azure Pwr Global Ltd | < 0.1% | 161,500 | 1.8M USD | −33.1% reduced | Q3 2020 8 quarters |
| The Realreal Inc | < 0.1% | 734,600 | 1.8M USD | −36.6% reduced | Q1 2022 2 quarters |
| Adicet Bio Inc | < 0.1% | 124,900 | 1.8M USD | −68.6% reduced | Q1 2021 6 quarters |
| Childrens Pl Inc New | < 0.1% | 45,200 | 1.8M USD | −61.1% reduced | Q1 2019 14 quarters |
| NCLH Norwegian Cruise Line Holdings | < 0.1% | 152,908 | 1.7M USD | −67.0% reduced | Q3 2021 4 quarters |
| Harpoon Therapeutics Inc | < 0.1% | 870,700 | 1.7M USD | −25.5% reduced | Q4 2021 3 quarters |
| Sm Energy Co | < 0.1% | 46,900 | 1.6M USD | −67.6% reduced | Q3 2021 4 quarters |
| APO Apollo Global Management | < 0.1% | 32,800 | 1.6M USD | −40.0% reduced | Q1 2022 2 quarters |
| Renew Energy Global PLC | < 0.1% | 245,700 | 1.6M USD | −34.4% reduced | Q3 2021 4 quarters |
| Informatica Inc | < 0.1% | 75,300 | 1.6M USD | −51.7% reduced | Q4 2021 3 quarters |
| Builders Firstsource Inc | < 0.1% | 27,300 | 1.5M USD | −88.9% reduced | Q1 2021 6 quarters |
| Nextgen Healthcare Inc | < 0.1% | 83,600 | 1.5M USD | −67.9% reduced | Q4 2021 3 quarters |
| Lincoln Natl Corp Ind | < 0.1% | 29,100 | 1.4M USD | −80.9% reduced | Q3 2021 4 quarters |
| Mogo Inc | < 0.1% | 1,400,000 | 1.2M USD | −30.3% reduced | Q1 2021 6 quarters |
| PAYX Paychex | < 0.1% | 10,360 | 1.2M USD | −78.9% reduced | Q4 2021 3 quarters |
| ESS Essex Property Trust | < 0.1% | 4,200 | 1.1M USD | −92.9% reduced | Q4 2021 3 quarters |
| Eledon Pharmaceuticals Inc | < 0.1% | 428,360 | 1.0M USD | −22.9% reduced | Q1 2021 6 quarters |
| Convey Health Solutions Hldg | < 0.1% | 100,000 | 1.0M USD | −65.2% reduced | Q2 2021 5 quarters |
| Freyr Battery | < 0.1% | 151,104 | 1.0M USD | −50.1% reduced | Q3 2021 4 quarters |
| Atricure Inc | < 0.1% | 24,400 | 997.0K USD | −84.7% reduced | Q4 2021 3 quarters |
| Coherus Biosciences Inc | < 0.1% | 135,800 | 983.0K USD | −80.8% reduced | Q4 2021 3 quarters |
| Theravance Biopharma Inc | < 0.1% | 105,900 | 959.0K USD | −83.9% reduced | Q3 2021 4 quarters |
| Trinseo PLC | < 0.1% | 22,800 | 877.0K USD | −0.4% reduced | Q1 2022 2 quarters |
| Fusion Pharmaceuticals Inc | < 0.1% | 328,868 | 819.0K USD | −6.0% reduced | Q4 2020 7 quarters |
| Pardes Biosciences Inc | < 0.1% | 266,400 | 818.0K USD | −38.4% reduced | Q4 2021 3 quarters |
| Navitas Semiconductor Corp | < 0.1% | 207,600 | 801.0K USD | −45.5% reduced | Q4 2021 3 quarters |
| Cytokinetics Inc | < 0.1% | 19,633 | 771.0K USD | −98.8% reduced | Q2 2019 13 quarters |
| Neuropace Inc | < 0.1% | 149,199 | 739.0K USD | −28.7% reduced | Q4 2021 3 quarters |
| Ishares TR | < 0.1% | 10,000 | 736.0K USD | −60.0% reduced | Q4 2021 3 quarters |
| Community Health Sys Inc New | < 0.1% | 193,200 | 725.0K USD | −93.0% reduced | Q4 2021 3 quarters |
| Centessa Pharmaceuticals PLC | < 0.1% | 133,600 | 651.0K USD | −85.3% reduced | Q2 2021 5 quarters |
| F-Star Therapeutics Inc | < 0.1% | 91,761 | 574.0K USD | −89.2% reduced | Q1 2021 6 quarters |
| Revolution Medicines Inc | < 0.1% | 27,667 | 539.0K USD | −92.9% reduced | Q1 2022 2 quarters |
| Deutsche Bank A G | < 0.1% | 61,576 | 538.0K USD | −88.4% reduced | Q1 2022 2 quarters |
| RCL Royal Caribbean Group | < 0.1% | 14,200 | 496.0K USD | −42.5% reduced | Q1 2021 6 quarters |
| Conmed Corp | < 0.1% | 5,040 | 483.0K USD | −94.5% reduced | Q3 2021 4 quarters |
| Northwest Nat Hldg Co | < 0.1% | 8,500 | 451.0K USD | −87.5% reduced | Q1 2022 2 quarters |
| Surmodics Inc | < 0.1% | 11,500 | 428.0K USD | −5.0% reduced | Q4 2021 3 quarters |
| Sharecare Inc | < 0.1% | 265,000 | 419.0K USD | −64.5% reduced | Q3 2021 4 quarters |
| CIFR Cipher Mining | < 0.1% | 266,700 | 365.0K USD | −43.3% reduced | Q4 2021 3 quarters |
| Petmed Express Inc | < 0.1% | 16,900 | 336.0K USD | −94.3% reduced | Q3 2021 4 quarters |
| Lava Therapeutics NV | < 0.1% | 111,993 | 330.0K USD | −4.3% reduced | Q3 2021 4 quarters |
| Airsculpt Technologies Inc | < 0.1% | 49,200 | 292.0K USD | −82.4% reduced | Q4 2021 3 quarters |
| SNAP Snap | < 0.1% | 21,552 | 283.0K USD | −94.1% reduced | Q2 2021 5 quarters |
| Ligand Pharmaceuticals Inc | < 0.1% | 2,900 | 259.0K USD | −96.6% reduced | Q4 2021 3 quarters |
| PNC PNC Financial Services | < 0.1% | 1,644 | 259.0K USD | −96.5% reduced | Q1 2022 2 quarters |
| Praxis Precision Medicines I | < 0.1% | 100,000 | 245.0K USD | −92.5% reduced | Q4 2020 7 quarters |
| Aerie Pharmaceuticals Inc | < 0.1% | 31,900 | 239.0K USD | −96.8% reduced | Q1 2022 2 quarters |
| Ringcentral Inc | < 0.1% | 4,421 | 231.0K USD | −98.1% reduced | Q2 2020 9 quarters |
| Aptinyx Inc | < 0.1% | 410,416 | 229.0K USD | −63.2% reduced | Q4 2021 3 quarters |
| Liquidia Corporation | < 0.1% | 50,000 | 218.0K USD | −82.3% reduced | Q1 2022 2 quarters |
| Employers HLDGS Inc | < 0.1% | 4,200 | 176.0K USD | −95.6% reduced | Q3 2021 4 quarters |
| Athira Pharma Inc | < 0.1% | 55,000 | 168.0K USD | −92.8% reduced | Q4 2021 3 quarters |
| Gol Linhas Aereas Inteligent | < 0.1% | 40,900 | 139.0K USD | −81.2% reduced | Q3 2021 4 quarters |
| Cano Health Inc | < 0.1% | 22,500 | 99.0K USD | −97.4% reduced | Q1 2022 2 quarters |
| IREN IREN | < 0.1% | 16,500 | 55.0K USD | −24.0% reduced | Q4 2021 3 quarters |
| Electronic Arts Inc | < 0.1% | 394 | 48.0K USD | −99.9% reduced | Q2 2021 5 quarters |
| Aurora Innovation Inc | < 0.1% | 9,562 | 18.0K USD | −96.8% reduced | Q4 2021 3 quarters |
| Select Energy Svcs Inc | < 0.1% | 2,200 | 15.0K USD | −63.9% reduced | Q1 2022 2 quarters |
| James Riv Group Ltd | < 0.1% | 100 | 2.0K USD | −91.7% reduced | Q3 2021 4 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 358 option positions, value of the underlying shares as reported 2.4B USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- SPDR S&P 500 ETF TR Put 643.9M USD
- Invesco Db Multi-Sector Comm Call 96.1M USD
- Select Sector SPDR TR Call 57.1M USD
- Alibaba Group (ADR) Call 48.3M USD
- Deere & Company Call 44.9M USD
- Ishares TR Put 34.1M USD
- American Airls Group Inc Put 30.2M USD
- SPDR Ser TR Put 29.9M USD
- Kohls Corp Call 28.6M USD
- SPDR S&P 500 ETF TR Call 28.3M USD
Plus 38 positions in convertible bonds and bonds worth 350.2M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Novavax Inc principal 31.9M USD 32.0M USD
- Dish Network Corporation principal 37.0M USD 26.2M USD
- Spotify USA Inc principal 29.5M USD 23.5M USD
- Sarepta Therapeutics Inc principal 17.0M USD 21.5M USD
- Lumentum HLDGS Inc principal 20.0M USD 20.6M USD
- Docusign Inc principal 17.5M USD 16.2M USD
- Sunnova Energy Intl Inc. principal 18.3M USD 14.3M USD
- Wayfair Inc principal 17.5M USD 14.0M USD
- Wayfair Inc principal 20.5M USD 13.8M USD
- Ford Mtr Co Del principal 15.0M USD 13.7M USD
Breakdown by sector
- Technology 10.0%
- Consumer Discretionary 7.5%
- Health Care 7.2%
- Financials 6.2%
- Industrials 4.9%
- Communication Services 4.0%
- Consumer Staples 3.4%
- Utilities 3.3%
- Energy 2.6%
- Materials 1.8%
- Real Estate 1.4%
- not in our coverage 47.6%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors